Olivry T, Chan LS. Autoimmune blistering dermatoses in domestic animals. Clin Dermatol. 2001 Nov-Dec. 19(6):750-60. [QxMD MEDLINE Link].
Hill PB, Brain P, Collins D, Fearnside S, Olivry T. Putative paraneoplastic pemphigus and myasthenia gravis in a cat with a lymphocytic thymoma. Vet Dermatol. 2013 Dec. 24(6):646-9, e163-4. [QxMD MEDLINE Link].
Olivry T, Chan LS, Xu L, et al. Novel feline autoimmune blistering disease resembling bullous pemphigoid in humans: IgG autoantibodies target the NC16A ectodomain of type XVII collagen (BP180/BPAG2). Vet Pathol. 1999 Jul. 36(4):328-35. [QxMD MEDLINE Link].
Olivry T, Mirsky ML, Singleton W, et al. A spontaneously arising porcine model of bullous pemphigoid. Arch Dermatol Res. 2000 Jan. 292(1):37-45. [QxMD MEDLINE Link].
Olivry T, Dunston SM, Schachter M, et al. A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions. J Autoimmun. 2001 Jun. 16(4):411-21. [QxMD MEDLINE Link].
Busquets AC, Jean-Baptiste S, Chan LS. Primary brain B-cell lymphoma developing in a patient with pemphigus vulgaris receiving immunosuppressive drugs. Br J Dermatol. 2001 Sep. 145(3):510-2. [QxMD MEDLINE Link].
Chan LS, Vanderlugt CJ, Hashimoto T, et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol. 1998 Feb. 110(2):103-9. [QxMD MEDLINE Link].
Chan LS, Soong HK, Foster CS, Hammerberg C, Cooper KD. Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome. JAMA. 1991 Sep 18. 266(11):1543-6. [QxMD MEDLINE Link].
Chan LS, Hammerberg C, Cooper KD. Significantly increased occurrence of HLA-DQB1*0301 allele in patients with ocular cicatricial pemphigoid. J Invest Dermatol. 1997 Feb. 108(2):129-32. [QxMD MEDLINE Link].
Delgado JC, Turbay D, Yunis EJ, et al. A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A. 1996 Aug 6. 93(16):8569-71. [QxMD MEDLINE Link]. [Full Text].
Amagai M, Nishikawa T, Nousari HC, Anhalt GJ, Hashimoto T. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest. 1998 Aug 15. 102(4):775-82. [QxMD MEDLINE Link]. [Full Text].
Mustafa MB, Porter SR, Smoller BR, Sitaru C. Oral mucosal manifestations of autoimmune skin diseases. Autoimmun Rev. 2015 Oct. 14 (10):930-51. [QxMD MEDLINE Link].
Fernández S, España A, Navedo M, Barona L. Study of oral, ear, nose and throat involvement in pemphigus vulgaris by endoscopic examination. Br J Dermatol. 2012 Jun 20. [QxMD MEDLINE Link].
Said S, Golitz L. Vesiculobullous eruptions of the oral cavity. Otolaryngol Clin North Am. 2011 Feb. 44(1):133-60, vi. [QxMD MEDLINE Link].
Anhalt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med. 1990 Dec 20. 323(25):1729-35. [QxMD MEDLINE Link].
Patel RS, Harman KE, Nichols C, Burd RM, Pavord S. Acquired haemophilia heralded by bleeding into the oral mucosa in a patient with bullous pemphigoid, rheumatoid arthritis, and vitiligo. Postgrad Med J. 2006 Jan. 82(963):e3. [QxMD MEDLINE Link]. [Full Text].
Chan LS, Regezi JA, Cooper KD. Oral manifestations of linear IgA disease. J Am Acad Dermatol. 1990 Feb. 22(2 Pt 2):362-5. [QxMD MEDLINE Link].
Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002 Mar. 138(3):370-9. [QxMD MEDLINE Link].
Robinson JC, Lozada-Nur F, Frieden I. Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Oct. 84(4):349-55. [QxMD MEDLINE Link].
Sano SM, Quarracino MC, Aguas SC, et al. Sensitivity of direct immunofluorescence in oral diseases. Study of 125 cases. Med Oral Patol Oral Cir Bucal. 2008 May 1. 13(5):E287-91. [QxMD MEDLINE Link].
Fine JD, Neises GR, Katz SI. Immunofluorescence and immunoelectron microscopic studies in cicatricial pemphigoid. J Invest Dermatol. 1984 Jan. 82(1):39-43. [QxMD MEDLINE Link].
Celentano A, Cirillo N. Desmosomes in disease: a guide for clinicians. Oral Dis. 2016 Jun 22. [QxMD MEDLINE Link].
Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol. 1986 Feb 15. 136(4):1231-5. [QxMD MEDLINE Link].
Kamaguchi M, Iwata H, Miyauchi T, Ujiie H, Ujiie I, Nomura T, et al. The identification of autoantigens in mucous membrane pemphigoid using immortalized oral mucosal keratinocytes. J Oral Pathol Med. 2019 Jan. 48 (1):60-67. [QxMD MEDLINE Link].
Chen M, Chan LS, Cai X, O'Toole EA, Sample JC, Woodley DT. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol. 1997 Jan. 108(1):68-72. [QxMD MEDLINE Link].
España A, Fernandez S. Exploring beyond the oral mucosa in patients affected with autoimmune blistering diseases: the importance of endoscopic procedures. J Eur Acad Dermatol Venereol. 2016 Sep 14. [QxMD MEDLINE Link].
Cranney A, Adachi JD. Corticosteroid-induced osteoporosis: a guide to optimum management. Treat Endocrinol. 2002. 1(5):271-9. [QxMD MEDLINE Link].
Sambrook PN. How to prevent steroid induced osteoporosis. Ann Rheum Dis. 2005 Feb. 64(2):176-8. [QxMD MEDLINE Link].
Borradori L, Lombardi T, Samson J, Girardet C, Saurat JH, Hugli A. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol. 2001 Mar. 137(3):269-72. [QxMD MEDLINE Link].
Kong HH, Prose NS, Ware RE, Hall RP 3rd. Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab). Pediatr Dermatol. 2005 Sep-Oct. 22(5):461-4. [QxMD MEDLINE Link].
Salopek TG, Logsetty S, Tredget EE. Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder. J Am Acad Dermatol. 2002 Nov. 47(5):785-8. [QxMD MEDLINE Link].
Schmidt E, Benoit S, Brocker EB, Zillikens D, Goebeler M. Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab. Arch Dermatol. 2006 Feb. 142(2):147-50. [QxMD MEDLINE Link].
Craythorne E, du Viver A, Mufti GJ, Warnakulasuriya S. Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations. J Oral Pathol Med. 2011 Sep. 40(8):616-20. [QxMD MEDLINE Link].
Murrell DF, Peña S, Joly P, et al. Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts. J Am Acad Dermatol. 2018 Feb 10. [QxMD MEDLINE Link].
Lamberts A, Euverman HI, Terra JB, Jonkman MF, Horváth B. Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases. Front Immunol. 2018. 9:248. [QxMD MEDLINE Link].
Poskitt L, Wojnarowska F. Treatment of cicatricial pemphigoid with tetracycline and nicotinamide. Clin Exp Dermatol. 1995 May. 20(3):258-9. [QxMD MEDLINE Link].
Nousari HC, Deterding R, Wojtczack H, et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med. 1999 May 6. 340(18):1406-10. [QxMD MEDLINE Link].
van der Waal RI, Pas HH, Nousari HC, et al. Paraneoplastic pemphigus caused by an epithelioid leiomyosarcoma and associated with fatal respiratory failure. Oral Oncol. 2000 Jul. 36(4):390-3. [QxMD MEDLINE Link].
American College of Rheumatology. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines. Arthritis Rheum. 1996 Nov. 39(11):1791-801. [QxMD MEDLINE Link].
Lozada-Nur F, Huang MZ, Zhou GA. Open preliminary clinical trial of clobetasol propionate ointment in adhesive paste for treatment of chronic oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol. 1991 Mar. 71(3):283-7. [QxMD MEDLINE Link].
Lozada-Nur F, Miranda C, Maliksi R. Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol. 1994 Jun. 77(6):598-604. [QxMD MEDLINE Link].
Rogers RS 3rd, Seehafer JR, Perry HO. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol. 1982 Feb. 6(2):215-23. [QxMD MEDLINE Link].